• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Chemical Profiling and Antihyperglycaemic Study on Butanol Fraction of Chlorophytum alismifolium Baker (Liliaceae)
  • VIEWS 1247
  • PDF 297

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v20i3.cp

Year: 2021, Volume: 20, Issue: 3, Pages: 38-42

Original Article

Chemical Profiling and Antihyperglycaemic Study on Butanol Fraction of Chlorophytum alismifolium Baker (Liliaceae)

Abubakar Abdulhakim1,*, Omogbai E K Inanemo2, Nazifi A Balarabe3, Sani M Bashir1

1Department of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria, Nigeria
2Department of Pharmacology and Toxicology, University of Benin, Benin City, Nigeria
3Department of Pharmacology and Therapeutics, Bayero University, Kano, Nigeria

* Corresponding author email: [email protected]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Purpose: Diabetes mellitus is a disorder associated with debilitating complications. This study was aimed at evaluating the chemical profile and antihyperglycaemic effect of butanol fraction of Chlorophytum alismifolium. Methodology: The powdered plant was extracted sequentially using soxhlet apparatus with solvents of varying polarities until butanol fraction was obtained. GC-MS analysis, phytochemical screening and acute toxicity studies were carried out. Antihyperglycaemic study was carried out using alloxan-induced hyperglycaemia in rats. Male Wistar rats were injected with 120 mg/kg of alloxan intraperitoneally, the rats with fasting blood glucose levels between 200 and 350 mg/dL were considered hyperglycaemic. Experimental groups were set up using normal rats in group I and hyperglycaemic rats in five groups of six rats each. Group II was the hyperglycaemic control while groups III, IV and V received the butanol fraction of C. alismifolium at 250, 500 and 1000 mg/kg respectively. Group VI received glimepiride 1 mg/kg. Blood glucose levels were monitored before treatment at 0 hour and 1, 2, 3 and 5 hours after treatment. Findings: Phytochemical screening revealed the presence of alkaloids, saponins, flavonoids, glycosides and triterpenes while GC-MS analysis revealed the presence of thirteen compounds some of which include; isoxazolidine, isothiazole and acetamide. Oral median lethal dose of the extract in rats was estimated to be >5,000 mg/kg. The butanol fraction of C. alismifolium at all the doses tested showed significant (p<0.05) blood glucose lowering effect when compared over time. Conclusion: The findings from this research showed that butanol fraction of Chlorophytum alismifolium possesses important compounds with antihyperglycaemic activity.

Keywords: Chlorophytum alismifolium, Hyperglycaemia, Gas chromatography-mass spectrometry

References

  1. International Diabetes Federation Diabetes Atlas (Eighth edition). (pp. 1-150) 2017.
  2. Kennedy MSN, Masharani U. Pancreatic hormones and antidiabetic drugs. In: Katzung BG., ed. In: Basic and Clinical Pharmacology. (pp. 747-814) McGraw-Hill Education. 2018.
  3. Ayodhya S, Kusum S, Saxena A. Hypoglycaemic activity of different extracts of various herbal plants. International Journal of Research in Ayurveda and Pharmacy. 2010;1(1):212–224.
  4. Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—A concise review. Saudi Pharmaceutical Journal. 2016;24(5):547–553. Available from: https://dx.doi.org/10.1016/j.jsps.2015.03.013
  6. Mclnnes AD. Diabetic foot disease in the United Kingdom: about time to put feet first. Journal of Foot Ankle Research. 2012;5(26):1–7.
  7. Satoskar RS, Bhandarkar SD, Ainapure SS. Pharmacology and pharmacotherapeutics. Mumbai, India. 1999.
  8. Tripathi KD. Essentials of Medical Pharmacology (seventh ). Jaypee Brothers Medical Publishers Ltd. 2013.
  9. Yusuff KB, Obe O, Joseph BY. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria. Pharmacy World & Science. 2008;30(6):876–883. Available from: https://dx.doi.org/10.1007/s11096-008-9243-2
  10. Abdel-Azim NS, Shams KA, Shahat AAA, MMEM, Ismail SI, Hammouda FM. Egyptian Herbal Drug Industry: Challenges and Future Prospects. Research Journal of Medicinal Plant. 2011;5(2):136–144. Available from: https://dx.doi.org/10.3923/rjmp.2011.136.144
  11. Abubakar A, Danjuma NM, Odoma S, Nazifi AB. Antinociceptive and anti-inflammatory activities of the methanol extract of Chlorophytum alismifolium tubers. Journal of Pharmacy & Bioresources. 2016;13(2):155. Available from: https://dx.doi.org/10.4314/jpb.v13i2.11
  12. Abubakar A, Danjuma NM, Chindo BA, Nazifi AB. Ameliorative Effects of Methanol tuber Extract of Chlorophytum alismifolium Baker on Hyperglycaemia- induced Haematological and Hepato-renal Alterations in Rats. Nigerian Journal of Pharmaceutical Sciences. 2017;16:30–39.
  13. Abubakar A, Danjuma NM, Chindo BA, Nazifi AB. Anti-hyperglycaemic activity of tuber extract of Chlorophytum alismifolium Baker in streptozotocin-induced hyperglycaemic rats. Bulletin of Faculty of Pharmacy, Cairo University. 2018;56(1):60–67. Available from: https://dx.doi.org/10.1016/j.bfopcu.2017.11.003
  14. Sahil K, Prashant B, Akansha M, Premjeet S, Devashish R. Gas chromatography-mass spectrometry: applications. International Journal of Pharmaceutical and Biological Archives. 2011;2:1544–1560.
  15. Thomas E, Aneesh TP, Della GT, Anandan R. GC-MS anal- ysis of phytochemical compounds present in the rhizomes of Nervilia aragoana Gaud. Asian Journal of Pharmacy and Clinical Research. 2013;6:68–74.
  16. Evans WC. Trease and Evans Pharmacognosy. London, U.K.. Elsevier Health Sciences. 2009.
  18. Lorke D. A new approach to practical acute toxicity testing. Archives of Toxicology. 1983;54(4):275–287. Available from: https://dx.doi.org/10.1007/bf01234480
  19. Cooperstein SJ, Watkins D. Action of Toxic Drugs on Islet Cells. In: The Islets of Langerhans. (pp. 387-425) Elsevier. 1981.
  20. Schlienger JL. Type 2 diabetes complications. La Presse Médicale. 2013;42:839–848.
  21. Saravanan G, Pari L. Hypoglycaemic and Antihyperglycaemic Effect of Syzygium cumini Bark in Streptozotocin-Induced Diabetic Rats. Journal of Pharmacology and Toxicology. 2007;3(1):1–10.
  22. Szkudelski T. The mechanism of alloxan and streptozoto- cin action in beta cells of the rat’s pancreas. Physiological Research. 2001;50:537–546.
  23. Watkins D, Cooperstein SJ, Lazarow A. Effect of alloxan on permeability of pancreatic islet tissue in vitro. American Journal of Physiology-Legacy Content. 1964;207(2):436–440. Available from: https://dx.doi.org/10.1152/ajplegacy.1964.207.2.436
  24. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 1995;2(2):137–189. Available from: https://dx.doi.org/10.1016/s0944-7113(11)80059-0
  25. Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacological Review. 2000;52:673–751.
  26. Kaushik N. Saponins of Chlorophytum Species. Phytochemistry Reviews. 2005;4(2-3):191–196. Available from: https://dx.doi.org/10.1007/s11101-005-2607-5
  27. Kwon DY, Kim YS, Ryu SY, Choi YH, Cha MR, Yang HJ. Platyconic acid, a saponin from Platycodi radix, improves glucose homeostasis by enhancing insulin sensitivity in vitro and in vivo. European Journal of Nutrition. 2012;51(5):529–540. Available from: https://dx.doi.org/10.1007/s00394-011-0236-x
  28. Metwally NS, Mohamed AM, Elsharabasy FS. Chemical constituents of the Egyptian Plant Anabasis articulata (Forssk) Moq and its antidiabetic effects on rats with streptozotocin-induced diabetic hepatopathy. Journal of Applied Pharmaceutical Science. 2012;2:54–65.
  29. Lee KT, Jung TW, Lee HJ, Kim SG, Shin YS, Whang WK. The antidiabetic effect of ginsenoside Rb2 via activation of AMPK. Archives of Pharmacal Research. 2011;34(7):1201–1208. Available from: https://dx.doi.org/10.1007/s12272-011-0719-6
  30. Sridharan S, Meena V, Kavitha V, Agnel A, John N. GC-MS study and phytochemical profiling of Mimosa pudica Linn. Journal of Pharmaceutical Research. 2011;4:741–742.
  31. Taylor SI, Accili D, Imai Y. Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM? Diabetes. 1994;43(6):735–740. Available from: https://dx.doi.org/10.2337/diab.43.6.735
  32. Shinkai H, Onogi S, Tanaka M, Shibata T, Iwao M, Wakitani K, et al. Isoxazolidine-3,5-dione and Noncyclic 1,3-Dicarbonyl Compounds as Hypoglycemic Agents. Journal of Medicinal Chemistry. 1998;41(11):1927–1933. Available from: https://dx.doi.org/10.1021/jm970771m
  33. Settimo FD, Primofiore G, Motta CL, Sartini S, Taliani S, Simorini F, et al. Naphtho[1,2-d]isothiazole Acetic Acid Derivatives as a Novel Class of Selective Aldose Reductase Inhibitors. Journal of Medicinal Chemistry. 2005;48(22):6897–6907. Available from: https://dx.doi.org/10.1021/jm050382p

Copyright

© 2021 Published by Krupanidhi Educational Trust. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/)

  • 26 November 2021

Year: 2021, Volume: 20, Issue: 3


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.